z-logo
Premium
Preclinical models: Needed in translation? A Pro/Con debate
Author(s) -
Philips Thomas,
Rothstein Jeffrey D.,
Pouladi Mahmoud A.
Publication year - 2014
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.26010
Subject(s) - translation (biology) , neuroscience , medline , medicine , psychology , biology , genetics , biochemistry , messenger rna , gene
The discovery of the causative mutations and many of the predisposing risk factors for neurodegenerative disorders such as Amyotrophic Lateral Sclerosis, Alzheimer's, Parkinson's, and Huntington's disease (HD), has led to the development of a large number of genetic animal models of disease. In the case of HD, for example, over 20 different transgenic rodent models have been generated. These models have been of immense value in providing novel insights into mechanisms of disease, with the promise of accelerating the development of therapies that can delay the onset or slow the progression of the disease. Yet, despite extensive use of such models, no effective treatment for HD has been developed. Here, we discuss the value of animal models, highlighting their strengths and shortcomings in the context of translational research for HD. © 2014 International Parkinson and Movement Disorder Society

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here